Drawing for CODIS

USPTO serial 99496902

CODIS

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MOULTON, NICHOLAS C
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with CODIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joel R. Samuels

Joel R. Samuels Harness, Dickey and Pierce, P.L.C.7733 Forsyth BoulevardSuite 2200Saint Louis, MO 63105

Goods and services

ClassDescriptionStatusFirst use
001Magnesium carbonate; Particulate precursor components in the nature of chemical additives for use in the manufacture of pharmaceutical tablets and nutritional and dietary supplements; chemicals sold in bulk for use in the manufacturing, processing and packing of nutritional supplements, vitamins, and pharmaceutical products and preparations; chemical encased in a matrix which is sold in bulk for manufacturing, processing or repacking of chemicals; Chemical tastemasking additives, stability and flavor enhancers, for use in the manufacture of pharmaceuticals, namely, antihistamines, anti-nausea agents, neonatal agents, osteoporetic, nutraceuticals, and pharmaceuticals, namely, hormones, anti-infectives, and fertility agents; Excipients for use in the manufacture of pharmaceuticalsACTIVE—
005Dietary and nutritional supplements; active pharmaceutical ingredients (APIs), namely, Sevelamer Carbonate and Sevelamer Hydrochloride; drug delivery systems in the form of amorphous solid dispersions that facilitate the delivery of pharmaceutical preparations; spray-dried pharmaceutical products for treatment of hyperphosphatemiaACTIVE—
040Contract pharmaceutical manufacturing services in the field of pharmaceuticals; custom synthesis of active pharmaceutical ingredients (APIs); formulation of pharmaceutical preparations for others; Contract pharmaceutical manufacturing services in the nature of pharmaceutical spray drying services; Contract pharmaceutical manufacturing services in the nature of solvent spray drying services; Contract pharmaceutical manufacturing services in the nature of pharmaceutical tableting, encapsulation, and blending services; Contract pharmaceutical manufacturing services in the nature of packaging services for pharmaceuticals; Contract pharmaceutical manufacturing services in the nature of labeling services for pharmaceuticals; Contract pharmaceutical manufacturing services in the nature of processing of pharmaceutical intermediates; scale-up and commercial manufacturing of pharmaceutical products for others; consulting services in the field of manufacturingACTIVE—
042Pharmaceutical research and development; contract development services for pharmaceuticals; Pharmaceutical research and development in the nature of pharmaceutical product design and optimization; Pharmaceutical research and development in the nature of analytical testing of pharmaceuticals; Pharmaceutical research and development in the nature of stability testing; Pharmaceutical research and development in the nature of method development and validation; Pharmaceutical research and development in the nature of technology transfer in the field of pharmaceuticals; consulting services in the field of drug development and manufacturingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Sep 15, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 21, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 21, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 24, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2026DOCKASSIGNED TO EXAMINER—
Feb 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 14, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance